Detection of Myocardial Dysfunction in Non-severe Subarachnoid Hemorrhage (WFNS 1-2) Using Speckle-tracking Echocardiography (STRAIN)
SAH-STRAIN
1 other identifier
observational
117
1 country
1
Brief Summary
Subarachnoid hemorrhage (SAH) can cause transient myocardial dysfunction. Recently, it have been reported that myocardial dysfunctions that occur in SAH are associated with poor outcomes. It therefore appears essential to detect theses dysfunctions with the higher sensitivity as possible. Strain measurement using speckle-tracking echocardiography may detect myocardial dysfunction with great sensitivity. The main objective of this study is to assess the prevalence of myocardial dysfunction in "non-severe" SAH (defined by a WFNS grade 1 or 2), using speckle-tracking echocardiography. This study also aims to analyse Strain measurement with classical echocardiography and serum markers (troponin, BNP) of cardiac dysfunction.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2019
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 29, 2018
CompletedFirst Posted
Study publicly available on registry
December 3, 2018
CompletedStudy Start
First participant enrolled
January 2, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 25, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2021
CompletedJanuary 6, 2021
January 1, 2021
2 years
November 29, 2018
January 5, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Global Longitudinal Strain
It is calculated using values of longitudinal strain measured in the three-,four-, and two-chamber of the left ventricle of the heart. GLS is expressed as percentage. Strain is a measure of myocardial muscle fiber shortening during contraction and is calculated as the systolic segment shortening between end-systolic (ES) segment length (L) and end-diastolic (ED) length: strain = (-LES - LED)/LED x 100 %.
Day 1 of hospitalization
Secondary Outcomes (6)
Global Longitudinal Strain
Day 3 of hospitalization
Global Longitudinal Strain
Day 7 of hospitalization
Change of Left Ventricular Ejection Fraction using Simpson technique
Days 1, 3 and 7 of hospitalization
Change in serum troponin level
Days 1, 3 and 7 of hospitalization
Change in brain natriuretic peptide (BNP) level
Days 1, 3 and 7 of hospitalization
- +1 more secondary outcomes
Study Arms (1)
Patients with a "non-severe" subarachnoid hemorrhage
Interventions
Global Longitudinal Strain measure on day 1 of hospitalization
Eligibility Criteria
Patient older than 18 years hospitalized in neuro-intensive care unit with a "non-severe" subarachnoid hemorrhage (WFNS 1 or 2)
You may qualify if:
- patient older than 18 years
- hospitalized in neuro-intensive care unit with a "non-severe" subarachnoid hemorrhage (WFNS 1 or 2)
You may not qualify if:
- low echogenicity
- history of cardiac malformation or cardiac surgery
- severe valvular heart disease
- dilated cardiomyopathy
- acute coronary syndrome
- permanent arrythmia
- patient refusal
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
CHU de Bordeaux
Bordeaux, 33076, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 29, 2018
First Posted
December 3, 2018
Study Start
January 2, 2019
Primary Completion
December 25, 2020
Study Completion
January 1, 2021
Last Updated
January 6, 2021
Record last verified: 2021-01
Data Sharing
- IPD Sharing
- Will not share